No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
1232,-,개별종목,2024-08-27,삼성생명,재평가,울산청천,2301110137941 ,B05,99,Y,분기 ,2024-09-30,평가철회,평가철회,-,강성은, - ,강성은,김예림,김예림,평가철회,평가철회,신혜성프로,02-772-6845,hyesung414.shin@samsung.com,-,0
1236,-,개별종목,2024-08-27,삼성생명,재평가,진주청천,1911110041091 ,B05,99,Y,분기 ,2024-09-30,평가철회,평가철회,-,오수현, 1.0 ,오수현,김예림,김예림,평가철회,평가철회,신혜성프로,02-772-6845,hyesung414.shin@samsung.com,-,0
3787,-,기초자산,신영증권펀드(기초자산),경기-퀀텀&코리아오메가Follow-on슈퍼맨투자,재평가,닷,1101115686279 ,A07,0,-,분기,2024-09-30,평가철회,평가철회,-,김에스더, - ,김에스더,-,-,평가철회,평가철회,0,0,0,-,0
3849,-,기초자산,키움캐피탈펀드(기초자산),디씨피리스본사모투자,신규,럭스코,2301110051414 ,D02,0,-,분기 ,2024-09-30,2024-10-07,보고서제공X,-,채동우, - ,신규,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
3959,-,개별종목,2024-09-03,"한국투자증권(종합금융본부(구,기업금융투자부))(수익증권)",재평가,서린컴퍼니인수금융선순위대출,KBP2023120031,E01,0,-,분기 ,2024-09-30,평가철회,평가철회,-,대체평가3사업본부, - ,대체평가3사업본부,유수연,유수연,평가철회,평가철회,이서현주임,02-3276-5083,seohyun.lee@koreainvestment.com,-,0
4258,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,베노바이오,1101116822252 ,D02,0,-,분기,2024-09-30,평가철회,평가철회,-,이문수, - ,이문수,-,-,평가철회,평가철회,0,0,0,-,0
4259,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,"베노홀딩스(구,엔터메이트)",1101115518084 ,D02,0,-,분기,2024-09-30,평가철회,평가철회,-,상장, - ,상장,-,-,평가철회,평가철회,0,0,0,-,0
4270,상장보통주,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,스마트레이더시스템,1311110496206 ,A01,0,-,분기,2024-09-30,평가철회,평가철회,-,상장, - ,상장,-,-,평가철회,평가철회,0,0,0,-,0
4976,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,자란다,1101116095536 ,A07,98,-,분기,2024-09-30,평가철회,평가철회,-,심태진, - ,심태진,-,-,평가철회,평가철회,0,0,0,-,0
4977,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,"인터파크트리플(구,인터파크)",1101118251772 ,A01,0,-,분기,2024-09-30,2024-10-07,보고서제공X,-,김에스더, - ,김에스더,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5299,-,개별종목,2024-09-23,"한국투자증권(프로젝트금융3부)(구,부동산투자부)",재평가,천안노태공원,KBP2018030070,B07,0,-,분기,2024-09-30,2024-10-04,2024-10-14,-,김예림, 1.0 ,김예림,김예림,김예림,202409,[Y]금융기관,"박해서주임, 최유나주임","02-3276-5568, 02-3276-5479",112698@koreainvestment.com;111138@koreainvestment.com,회계반영,0
5300,ABL,개별종목,2024-09-23,"한국투자증권(프로젝트금융3부)(구,부동산투자부)",재평가,원주단계동주상복합개발사업브릿지대출,KBP2024030031,E01,0,-,분기,2024-09-30,2024-10-04,2024-10-14,-,대체평가3사업본부, - ,신규,김예림,김예림,202409,[Y]금융기관,"박해서주임, 최유나주임","02-3276-5568, 02-3276-5479",112698@koreainvestment.com;111138@koreainvestment.com,회계반영,0
5301,교환대상:메드팩토 상장 보통주,개별종목,2024-09-24,테라젠이텍스,재평가,테라젠이텍스,1101110724107 ,D01,9,-,분기,2024-09-30,2024-10-17,2024-10-24,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,정승면대리,02-3463-7111,smjung17@etexpharm.com,회계반영,0
5302,-,개별종목,2024-09-24,키움증권,신규,코리아오메가테크핀일호조합,KBP2022060139,B01,0,Y,분기 ,2024-09-30,2024-10-10,2024-10-18,2024-10-18,변혜진, 1.0 ,변혜진,오수현,오수현,202409,[Y]금융기관,재무팀이학인과장,02-3787-9741 ,hokijo@kiwoom.com; clark@kiwoom.com; jskim9900@kiwoom.com ,-,0
5303,-,기초자산,키움증권펀드(기초자산),코리아오메가테크핀일호조합,신규,자비스앤빌런즈,1311110420106 ,A01,0,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,김영하, 0.4 ,김영하,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5304,-,개별종목,2024-09-24,삼영엠텍,재평가,삼영엠텍,1943110005149 ,D02,2,-,미정,2021-06-11,2024-09-25,2024-10-02,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,조혜진담당,0,syjhj@sym-tek.co.kr,회계반영,0
5305,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스마트하이DGB디지털그린벤처펀드2호,신규,다비오,1101114805995 ,A07,77,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,오영석, - ,정은지,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5306,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스마트하이DGB디지털그린벤처펀드2호,신규,토트,1101117735909 ,A07,77,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,김에스더, - ,신규,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5307,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스마트하이DGB디지털그린벤처펀드2호,신규,코스모스랩,2341110120588 ,A07,77,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,신원준, - ,신규,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5308,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스마트하이DGB디지털그린벤처펀드2호,신규,나라스페이스테크놀로지,1101115682201 ,A07,77,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,김에스더, - ,김에스더,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5309,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스마트하이DGB디지털그린벤처펀드2호,신규,"이노로보틱스(구,이노6)",1358110212993 ,A05,77,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,윤광일, - ,김범준,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5310,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스마트하이DGB디지털그린벤처펀드2호,신규,코멤텍,1101113592155 ,A05,77,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,심태진, - ,심태진,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5311,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스마트하이DGB디지털그린벤처펀드2호,신규,폴라리스쓰리디,1717110137892 ,A07,1,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,변혜진, - ,변혜진,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5312,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,신규,핀테라퓨틱스,1101116662046 ,A07,0,-,분기,2024-09-30,2024-10-07,보고서제공X,-,조현우, - ,조현우,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5313,ABL,개별종목,2024-09-24,메리츠증권(구조화상품1팀),신규,메리밀라노,1101117093985 ,E01,0,-,분기,2024-09-30,2024-10-04,2024-10-07,-,대체평가3사업본부, - ,주식옵션팀,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,신소미주임,02-6454-4020,somi.shin@meritz.co.kr,회계반영,0
5314,-,개별종목,2024-09-24,메리츠증권(구조화상품1팀),재평가,미디어그로쓰캐피탈제1호,1101118187513 ,D06,0,Y,분기,2024-09-30,2024-10-04,2024-10-07,-,주식옵션팀, - ,주식옵션팀,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,신소미주임,02-6454-4020,somi.shin@meritz.co.kr,회계반영,0
5315,-,개별종목,2024-09-24,메리츠증권(구조화상품1팀),재평가,미디어그로쓰캐피탈제1호,1101118187513 ,D06,2,-,분기 ,2024-09-30,2024-10-04,2024-10-07,-,주식옵션팀, - ,주식옵션팀,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,신소미주임,02-6454-4020,somi.shin@meritz.co.kr,회계반영,0
5316,-,개별종목,2024-09-24,메리츠증권(구조화상품1팀),재평가,미디어그로쓰캐피탈제1호,1101118187513 ,D05,0,-,분기 ,2024-09-30,2024-10-04,2024-10-07,-,주식옵션팀, - ,주식옵션팀,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,신소미주임,02-6454-4020,somi.shin@meritz.co.kr,회계반영,0
5317,미디어그로쓰캐피탈제1호 기초자산,기초자산,2024-09-24,메리츠증권(구조화상품1팀),재평가,티빙,1101117641297 ,A01,0,-,분기,2024-09-30,2024-10-04,2024-10-07,-,신원준, 0.4 ,신원준,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,신소미주임,02-6454-4020,somi.shin@meritz.co.kr,-,0
